# Phase 2 sarcoma trials recruiting: 106 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 106 trials in phase 2 for sarcoma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 sarcoma trials: 106 rows for $5.30, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/sarcoma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 106
- Recruiting or not yet: 106
- Read on: November 19, 2026

## Trials

The 25 newest of 106, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 6, 2026 | NCT07920835 | A Multicenter Phase II Clinical Trial Evaluating 68Ga-HX01 Injection for PET/CT Imaging | Hexin (Suzhou) Pharmaceutical Technology Co., Ltd | Phase 2 | Recruiting | Soft Tissue Sarcoma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07920835) |
| November 5, 2026 | NCT07917949 | Zemetostat With Anlotinib in Patients With Recurrent/Metastatic Head and Neck Soft Tissue Sarcoma | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Phase 2 | Recruiting | Soft Tissue Sarcoma | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917949) |
| October 15, 2026 | NCT07874828 | PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A... | M.D. Anderson Cancer Center | Phase 2 | Recruiting | Sarcoma,Soft Tissue | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874828) |
| October 6, 2026 | NCT07861217 | Paediatric Sarcoma, Hybrid Imaging & FAPI - Raising the Diagnostic Standard for Paediatric Sarcoma Patients, Combining Novel Radiotracer... | Copenhagen University Hospital, Rigshospitalet | Phase 2 | Not yet recruiting | Sarcoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861217) |
| September 25, 2026 | NCT07842276 | Utidelone Capsules Combined With Doxorubicin for Advanced Soft Tissue Sarcoma | Beijing Biostar Pharmaceuticals Co., Ltd. | Phase 2 | Not yet recruiting | Soft Tissue Sarcoma (STS), Utidelone, Doxorubicin | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842276) |
| August 24, 2026 | NCT07781891 | RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT | M.D. Anderson Cancer Center | Phase 2 | Not yet recruiting | Ewing Sarcoma | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07781891) |
| August 3, 2026 | NCT07741877 | A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue Sarcoma | Iovance Biotherapeutics, Inc. | Phase 2 | Recruiting | Sarcoma, Soft Tissue Sarcoma (STS), Advanced Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma (UPS)... | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07741877) |
| July 7, 2026 | NCT07686367 | Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers | National Cancer Institute (NCI) | Phase 2 | Not yet recruiting | Metastatic Myxoid Liposarcoma, Metastatic Synovial Sarcoma, Unresectable Myxoid Liposarcoma, Unresectable Synovial... | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07686367) |
| June 16, 2026 | NCT07650838 | OVV-01 Injection Combined With AK112 Injection for the Treatment of Patients With Advanced Soft Tissue Sarcoma (STS) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 | Not yet recruiting | Soft Tissue Sarcoma (STS) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07650838) |
| June 16, 2026 | NCT07650656 | Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial | City of Hope Medical Center | Phase 2 | Recruiting | High Grade Sarcoma, Sarcoma | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07650656) |
| May 28, 2026 | NCT07612098 | Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 | Not yet recruiting | Soft Tissue Sarcoma (STS) | 274 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07612098) |
| May 22, 2026 | NCT07602049 | Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma | Sun Yat-sen University | Phase 2 | Recruiting | Soft Tissue Sarcoma (STS), Osteosarcoma | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07602049) |
| May 8, 2026 | NCT07576725 | Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial | Fred Hutchinson Cancer Center | Phase 2 | Not yet recruiting | Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8, Clinical... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07576725) |
| May 8, 2026 | NCT07575724 | Comparison of the Effects of Needle Biopsy Tract Resection and Non-resection on Recurrence Rate in Patients With Primary Extremity Sarcoma | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 2 | Not yet recruiting | Primary, Sarcoma | 3,300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575724) |
| April 23, 2026 | NCT07548177 | Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable... | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 2 | Recruiting | Alveolar Soft Part Sarcoma | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07548177) |
| April 2, 2026 | NCT07507773 | Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall | Centre Oscar Lambret | Phase 2 | Recruiting | Soft Tissue Sarcoma Adult, Soft Tissue Sarcoma (Excluding GIST), Soft Tissue Sarcoma of the Trunk and Extremities, Soft... | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07507773) |
| March 30, 2026 | NCT07501026 | Preoperative Spatially Fractionated Radiation Therapy (SFRT) in Soft Tissue Sarcoma (neoSFRT-SARC) | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 2 | Recruiting | Sarcoma | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07501026) |
| March 24, 2026 | NCT07491783 | Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial | Sichuan Enray Pharmaceutical Sciences Company | Phase 2 | Not yet recruiting | HNSCC, Soft Tissue Cancer | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07491783) |
| March 12, 2026 | NCT07467772 | Ph 2 Elacestrant in ER Positive Uterine Sarcomas | Dana-Farber Cancer Institute | Phase 2 | Recruiting | Uterine Sarcoma, Uterine Leiomyosarcoma, Endometrial Stromal Sarcoma, ESS, Perivascular Epithelioid Cell Tumors... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07467772) |
| March 9, 2026 | NCT07457775 | Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 2 | Not yet recruiting | Soft Tissue Sarcoma (Excluding GIST) | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07457775) |
| March 3, 2026 | NCT07447050 | Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial | University of California, Irvine | Phase 2 | Recruiting | Breast Cancer, Sarcoma, Gastric (Stomach) Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, Ovarian Cancer... | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07447050) |
| March 3, 2026 | NCT07444918 | Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors | Tianjin Medical University Cancer Institute and Hospital | Phase 2 | Not yet recruiting | Relapsed or Refractory Pediatric Malignant Solid Tumors (Including Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma... | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07444918) |
| January 22, 2026 | NCT07359053 | MAGNATE-S: Paclitaxel Polymer Micelles Combo in Advanced Sarcoma | Shanghai 6th People's Hospital | Phase 2 | Recruiting | Sarcoma | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359053) |
| January 15, 2026 | NCT07342322 | A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated... | First Affiliated Hospital of Guangxi Medical University | Phase 2 | Not yet recruiting | Soft Tissue Sarcoma (STS) | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07342322) |
| January 7, 2026 | NCT07321912 | Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma | Milton S. Hershey Medical Center | Phase 2 | Recruiting | Osteosarcoma, Ewing Sarcoma | 406 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07321912) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| M.D. Anderson Cancer Center | 7 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 6 |
| Fudan University | 5 |
| National Cancer Institute (NCI) | 5 |
| Oslo University Hospital | 3 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 3 |
| Sun Yat-sen University | 3 |
| Ruijin Hospital | 3 |
| University Health Network, Toronto | 3 |
| UNICANCER | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Institut Claudius Regaud | 2 |
| [Chia Tai Tianqing Pharmaceutical Group Co., Ltd.](https://specstream.ai/data/clinical-trials/company/chia-tai-tianqing-pharmaceutical-group-co-ltd) | 2 |
| City of Hope Medical Center | 2 |
| University of California, Irvine | 2 |
| Yonsei University | 2 |
| Iovance Biotherapeutics, Inc. | 1 |
| Hackensack Meridian Health | 1 |
| Northwestern University | 1 |
| Shanghai 6th People's Hospital | 1 |
| Swiss Cancer Institute | 1 |
| First Affiliated Hospital of Guangxi Medical University | 1 |
| QBiotics Group Limited | 1 |
| Dana-Farber Cancer Institute | 1 |
| AIDS Malignancy Consortium | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 39 |
| China | 33 |
| France | 9 |
| Norway | 4 |
| Italy | 4 |
| Canada | 4 |
| Denmark | 3 |
| South Korea | 3 |
| Switzerland | 2 |
| Uganda | 2 |
| United Kingdom | 2 |
| Germany | 2 |
| Spain | 2 |
| Poland | 1 |
| Argentina | 1 |
| Brazil | 1 |
| Mexico | 1 |
| Zimbabwe | 1 |
| Sweden | 1 |
| Australia | 1 |
| Japan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Packaging companies in the United States](https://specstream.ai/data/businesses/packaging-companies/united-states)
- [Engineering firms in the United States](https://specstream.ai/data/businesses/engineering-firms/united-states)
- [Advertising agencies in the United States](https://specstream.ai/data/businesses/advertising-agencies/united-states)
- [Pan Asian restaurants in the United States](https://specstream.ai/data/businesses/pan-asian-restaurants/united-states)
- [Environmental testing companies in the United States](https://specstream.ai/data/businesses/environmental-testing-companies/united-states)
- [Agricultural cooperatives in the United States](https://specstream.ai/data/businesses/agricultural-cooperatives/united-states)
